Page 21 - Codexis Inc News Today

Wall Street analysts expect that Codexis, Inc. (NASDAQ:CDXS – Get Rating) will report sales of $29.10 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Codexis’ earnings. The highest sales estimate is $31.70 million and the lowest is $27.58 million. Codexis posted sales of $18.03 million during […]

Codexis, Inc. (NASDAQ:CDXS – Get Rating) gapped up prior to trading on Thursday . The stock had previously closed at $20.10, but opened at $20.68. Codexis shares last traded at $20.13, with a volume of 11,329 shares changing hands. A number of equities analysts have recently weighed in on CDXS shares. Cowen started coverage on […]

Shares of Codexis, Inc. (NASDAQ:CDXS – Get Rating) have been given an average rating of “Buy” by the eight brokerages that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation on the company. The average […]

StockNews.com initiated coverage on shares of Codexis (NASDAQ:CDXS – Get Rating) in a report issued on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. CDXS has been the subject of a number of other reports. Cowen initiated coverage on Codexis in a research report on Wednesday, March 2nd. They set a […]

Wall Street brokerages expect that Codexis, Inc. (NASDAQ:CDXS – Get Rating) will report $29.60 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Codexis’ earnings, with estimates ranging from $27.60 million to $31.70 million. Codexis reported sales of $18.03 million during the same quarter last year, which […]

Biofuel Enzymes Market Demand And Industry Challenges During Covid-19 2022 | 2022-03-28 09:46:13

Taylor Frigon Capital Management LLC trimmed its stake in Codexis, Inc. (NASDAQ:CDXS – Get Rating) by 18.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 199,868 shares of the biotechnology company’s stock after selling 45,106 shares during the quarter. Codexis accounts for about 2.0% of Taylor Frigon Capital Management LLC’s holdings, making the stock […]

Codexis, Inc. (NASDAQ:CDXS – Get Rating) shares hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $16.48 and last traded at $16.55, with a volume of 4714 shares changing hands. The stock had previously closed at $16.97. Several brokerages have recently issued reports on CDXS. TheStreet lowered […]

Popular stock picker Cathie Wood's Ark Investment Management on Thursday stayed away from buying more shares in favorite stocks on the di...

DUBLIN--(BUSINESS WIRE)--The "Synthetic Biology: Global Markets" report has been added to ResearchAndMarkets.com's offering.The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-fre...